Pharma Pulse 2/4/25: Pharma Organizations Respond to Proposed Tariffs, Improve Asthma Management with Triple Inhaled Therapy & more

Pharma Organizations Respond to Proposed Tariffs

President Trump’s tariffs will include imported pharmaceuticals, among other items that will impact the industry.

Improve Asthma Management with Triple Inhaled Therapy

Many patients do not attain sufficient disease control with inhaled corticosteroids in combination with long-acting β-2 agonists and remain vulnerable to exacerbations.

What the Obesity Drugmakers Expect in 2025

Plus, the next AI winners and the chance of a TikTok sale.

Trump Imposes Trade Tariffs on Canada, Mexico, and China

What implications will these have on the pharma supply chain?

Pharmaceutical Executive on LinkedIn

Check out this exclusive interview with Casey McPherson, Founder and CEO of AlphaRose Therapeutics (formerly Chrysalis Genetics)!

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs